iBio, Inc. (IBIO)
1.67
-0.03
(-1.76%)
USD |
NASDAQ |
Jun 11, 12:55
iBio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -5.72K% |
| June 30, 2025 | -2.58K% |
| March 31, 2025 | |
| December 31, 2024 | -2.18K% |
| September 30, 2024 | |
| June 30, 2024 | -1.85K% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | -10.15K% |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -374.8% |
| December 31, 2021 | |
| September 30, 2021 | -6.18K% |
| June 30, 2021 | 23.22% |
| March 31, 2021 | -1.00K% |
| December 31, 2020 | -1.15K% |
| September 30, 2020 | -1.84K% |
| June 30, 2020 | -316.1% |
| March 31, 2020 | -4.87K% |
| December 31, 2019 | -1.20K% |
| September 30, 2019 | -4.13K% |
| Date | Value |
|---|---|
| June 30, 2019 | -566.5% |
| March 31, 2019 | -801.5% |
| December 31, 2018 | -686.6% |
| September 30, 2018 | -9.78K% |
| June 30, 2018 | -4.85K% |
| March 31, 2018 | -5.08K% |
| December 31, 2017 | -2.55K% |
| September 30, 2017 | -3.14K% |
| June 30, 2017 | -2.95K% |
| March 31, 2017 | -11.91K% |
| December 31, 2016 | -5.06K% |
| September 30, 2016 | -2.68K% |
| June 30, 2016 | -1.17K% |
| March 31, 2016 | -893.1% |
| December 31, 2015 | -1.68K% |
| September 30, 2015 | -1.13K% |
| June 30, 2015 | -596.5% |
| March 31, 2015 | -480.5% |
| December 31, 2014 | -450.4% |
| September 30, 2014 | -172.2% |
| June 30, 2014 | -557.1% |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | -213.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | -- |
| Ocugen, Inc. | -1.25K% |
| CytomX Therapeutics, Inc. | -177.9% |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.79% |
| Return on Assets | -53.78% |
| Return on Invested Capital | -59.54% |
| Return on Net Operating Assets | -262.6% |